Rezum
Rezum is a medical procedure with 12 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
5
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison Between Water Vapor Thermal Therapy and Prostatic Artery Embolization in Treatment of Benign Prostatic Hyperplasia
Comparing UroLift Experience Against Rezūm
Comparative Study Between Rezum and Tamsulosin
Comparing Rezum and Urolift
Catheterless Water Vapor Therapy for the Treatment of BPH
Clinical Trials (12)
Comparison Between Water Vapor Thermal Therapy and Prostatic Artery Embolization in Treatment of Benign Prostatic Hyperplasia
Comparing UroLift Experience Against Rezūm
Comparative Study Between Rezum and Tamsulosin
Comparing Rezum and Urolift
Catheterless Water Vapor Therapy for the Treatment of BPH
Optimized Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia
Modified Water Vapor Thermal Therapy in Management of Patients With Large-volume Benign Prostatic Hyperplasia
Rezum for 30-80ml Patients With Moderate-severe LUTS to Study Surgical Principles for Median Lobe Enlargement
Outcomes of MIST for BPH: A Single-Institution Prospective Study
One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia.
Outcomes of Water Vapor Thermal Therapy (REZUM) in Management of Symptomatic Patients With Benign Prostatic Enlargement
Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
All 12 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 12